March 8, 2022
OAKLAND, CA – Fabric Genomics, Inc., today announced that the Broad Institute of MIT and Harvard has selected the company to support the development and implementation of its clinical whole genome sequencing-based offerings. As part of the agreement, Fabric Genomics will provide the AI-based clinical decision support platform used to support the interpretation of clinical [...]
March 8, 2022
MOUNTAIN VIEW, Calif. -- DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical data into tangible insights and personalized treatments. The round was led by funds [...]
New, Innovative GC and GC-MS Product Portfolio Enables Greater Uptime and Efficiency
March 8, 2022
Updated GC and GC-MS portfolio from Thermo Fisher Scientific designed to deliver enhanced customer experience, easy adoption and simplified operations AUSTIN, Texas – Thermo Fisher Scientific Inc., the world leader in serving science, enables analytical testing laboratories across a variety of sectors, including food, environmental, industrial and pharma to now meet their ever-increasing efficiency and [...]
Nanalysis Scientific Corp. Announces Closing of Initial Equity Investment in Quad Systems
March 8, 2022
Calgary, Alberta -- (“Nanalysis” or the “Company”) in accordance with its press release dated January 18, 2022, the Company announces that it has funded the initial equity investment in Quad Systems AG (“Quad Systems”), acquiring 43% ownership and an option to purchase the remaining shares. “We are happy to have closed this initial portion of our [...]
GREINER BIO-ONE EXPANDS CELLDISC PORTFOLIO TO INCLUDE VERSIONS WITH CLOSED FILLING CAPS
March 7, 2022
To make your cell culture even safer, we have developed closed filling cups (-CF1 / -CF2) for the CELLdisc in close cooperation with our customers. Frickenhausen, March 2022 - Working in a highly regulated environment requires maximal security on sterility and hence a closed system for fluid transfer which excludes any opening of a cell [...]
March 7, 2022
NANJING/SUZHOU, China and COLOGNE, Germany and SINGAPORE -- Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their clinical translations, today announced the acquisition of Proteona Pte. Ltd., a Singapore-based precision medicine company offering single-cell biomarker discovery services to translational and clinical researchers across the globe. By acquiring [...]
New Benchtop MALDI-TOF Mass Spectrometer Features Dual-Polarity Ion Source
March 7, 2022
COLUMBIA, Md. -- Shimadzu Scientific Instruments introduces the MALDI-8030 benchtop linear matrix-assisted laser desorption ionization–time-of-flight (MALDI-TOF) mass spectrometer. Like its predecessor, innovative instrument design enables the MALDI-8030 to achieve performance specifications similar to those of larger, more expensive MALDI-TOF models in a significantly smaller footprint. This user-friendly compact instrument expands on the successful benchtop format of [...]
March 7, 2022
DNA sequencing veteran Kevin Corcoran joins as CEO SANTA CRUZ, Calif. -- Nooma Bio, Inc., an innovator in the use of dual-nanopore technology to detect genome-wide structural and epigenetic variation, has announced a new leadership team including DNA sequencing veteran Kevin Corcoran as Chief Executive Officer. Mr. Corcoran has more than 30 years of experience [...]
BIONANO GENOMICS APPOINTS DR. ALEKS RAJKOVIC TO ITS BOARD OF DIRECTORS
March 7, 2022
SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solution for visualization, interpretation and reporting of genomic data, today announced the appointment of Aleks Rajkovic, MD, PhD, to its board of directors. Dr. Rajkovic is currently the Chief Genomics Officer at [...]
March 4, 2022
Shimadzu Corporation and the AI startup company Epistra Inc. (Address: Minato City, Tokyo; Representative: Representative Director and CEO Yosuke Ozawa; hereinafter “Epistra”) agreed to jointly develop a solution for optimizing culturing parameters used to cultivate cells. The companies intend to commercialize the solution by 2024. The solution being developed will use a Shimadzu triple quadrupole [...]
